Kang Rhee-Hun, Hahn Sang-Woo, Choi Myoung-Jin, Lee Min-Soo
Depression Center, Korea University, Seoul, Korea.
Neuropsychobiology. 2007;56(1):1-5. doi: 10.1159/000109970. Epub 2007 Oct 17.
This study aimed to determine the relationship between the C825T polymorphism in the G-protein beta 3 subunit (GNB3) gene and the response to mirtazapine in a Korean population with major depressive disorder (MDD).
Mirtazapine was administered for 8 weeks to the 101 MDD patients who completed this study. All subjects were examined using the Structured Clinical Interview for DSM-IV, and the severity of depression was assessed using the 21-item Hamilton Depression Rating (HAMD-21) scale.
There was a significant main effect of time on the decrease in the HAMD-21 score during the 8-week study period. However, a main effect of or an interaction of genotype with time on the decrease in the HAMD-21 score during the 8-week study period was not found. ANOVA revealed no significant effects of the GNB3 C825T polymorphism on the decrease in the HAMD-21 score at each time period.
Although the C825T polymorphism of the GNB3 gene may affect the pathogenesis of MDD, our results do not support the hypothesis that this polymorphism is involved in the therapeutic response to mirtazapine in Korean patients with MDD.
本研究旨在确定韩国重度抑郁症(MDD)患者中G蛋白β3亚基(GNB3)基因的C825T多态性与米氮平反应之间的关系。
对完成本研究的101例MDD患者给予米氮平治疗8周。所有受试者均使用DSM-IV结构化临床访谈进行检查,并使用21项汉密尔顿抑郁量表(HAMD-21)评估抑郁严重程度。
在为期8周的研究期间,时间对HAMD-21评分降低有显著的主效应。然而,未发现基因型在为期8周的研究期间对HAMD-21评分降低有主效应或与时间的交互作用。方差分析显示,GNB3 C825T多态性在每个时间段对HAMD-21评分降低均无显著影响。
虽然GNB3基因的C825T多态性可能影响MDD的发病机制,但我们的结果不支持该多态性参与韩国MDD患者对米氮平治疗反应的假说。